Increased levels of circulating TGs in turn contribute to the development of CVD as most if not all VLDL secreted in conjunction with NAFLD are in the form of VLDL1 containing ApoC3 (ApoCIII) (for reviews, see[52-53]). This evidence concerns the gene APOC3 and metabolic dysfunction-associated steatotic liver disease.